Fresenius Medical Care AG (FMS)

Fresenius Medical Care AG Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Fresenius Medical Care AG stock has a target of 30, which predicts a 9.05% increase from the current stock price of 27.51.

Price Target: $30 (+9.05%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$30	$30	$30	$30
Change	+9.05%	+9.05%	+9.05%	+9.05%

* Price targets were last updated on May 12, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Fresenius Medical Care AG is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Macdonald Truist Securities	Truist Securities	Hold Maintains $25 → $30	Hold	Maintains	$25 → $30	+9.05%	May 12, 2025
David Macdonald Truist Securities	Truist Securities	Hold Maintains $23 → $25	Hold	Maintains	$23 → $25	-9.12%	Jan 6, 2025
David Macdonald Truist Securities	Truist Securities	Hold Maintains $22 → $23	Hold	Maintains	$22 → $23	-16.39%	Oct 7, 2024
David Macdonald Truist Securities	Truist Securities	Hold Maintains $24 → $22	Hold	Maintains	$24 → $22	-20.03%	Jul 31, 2024
David Macdonald Truist Securities	Truist Securities	Hold Maintains $21 → $24	Hold	Maintains	$21 → $24	-12.76%	May 15, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

19.87B

Increased by 2.74%

from 19.34B

Revenue Next Year

20.58B

Increased by 3.60%

from 19.87B

EPS This Year

3.71

Increased by 102.49%

from 1.83

EPS Next Year

4.09

Increased by 10.29%

from 3.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	17.86B	17.62B	19.40B	19.45B	19.34B	19.87B	20.58B	21.35B
Revenue Growth	2.19%	-1.35%	10.10%	0.29%	-0.61%	2.74%	3.60%	3.75%
EPS	3.96	3.31	2.30	1.70	1.83	3.71	4.09	4.70
EPS Growth	-0.01%	-16.44%	-30.60%	-25.97%	7.65%	102.49%	10.29%	15.04%
Forward PE	-	-	-	-	-	6.33	5.74	4.99
No. Analysts	-	-	-	-	-	25	24	14

Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	21.1B	22.0B	22.9B
Avg	19.9B	20.6B	21.4B
Low	18.8B	19.2B	19.9B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	9.1%	10.7%	11.4%
Avg	2.7%	3.6%	3.8%
Low	-2.8%	-3.4%	-3.5%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	4.45	5.33	6.38
Avg	3.71	4.09	4.70
Low	2.13	2.30	3.55

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	143.3%	43.9%	56.2%
Avg	102.5%	10.3%	15.0%
Low	16.2%	-37.9%	-13.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.